TRXADE HEALTH INC (MEDS) Stock Price & Overview

NASDAQ:MEDS • US89846A4058

7.59 USD
+0.35 (+4.83%)
At close: Sep 20, 2024
7.591 USD
+0 (+0.01%)
After Hours: 9/20/2024, 8:07:08 PM

The current stock price of MEDS is 7.59 USD. Today MEDS is up by 4.83%. In the past month the price decreased by -8.22%. In the past year, price increased by 12.78%.

MEDS Key Statistics

52-Week Range3.69 - 44.56
Current MEDS stock price positioned within its 52-week range.
1-Month Range6.43 - 8.31
Current MEDS stock price positioned within its 1-month range.
Market Cap
11.081M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-2.29
Dividend Yield
125.16%

MEDS Stock Performance

Today
+4.83%
1 Week
+3.55%
1 Month
-8.22%
3 Months
-16.59%
Longer-term
6 Months -68.47%
1 Year +12.78%
2 Years -55.22%
3 Years -89.72%
5 Years N/A
10 Years N/A

MEDS Stock Chart

TRXADE HEALTH INC / MEDS Daily stock chart

MEDS Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to MEDS. When comparing the yearly performance of all stocks, MEDS is a bad performer in the overall market: 75.38% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
MEDS Full Technical Analysis Report

MEDS Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to MEDS. The financial health of MEDS is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
MEDS Full Fundamental Analysis Report

MEDS Earnings

Next Earnings DateN/A
Last Earnings DateJul 22, 2024
PeriodQ2 / 2024
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise -99.18%
MEDS Earnings History

MEDS Forecast & Estimates

7 analysts have analysed MEDS and the average price target is 6.89 USD. This implies a price decrease of -9.29% is expected in the next year compared to the current price of 7.59.

For the next year, analysts expect an EPS growth of 57.14% and a revenue growth 4.1% for MEDS


Analysts
Analysts82.86
Price Target6.89 (-9.22%)
EPS Next Y57.14%
Revenue Next Year4.1%
MEDS Forecast & Estimates

MEDS Groups

Sector & Classification

Index Membership

MEDS Financial Highlights

Over the last trailing twelve months MEDS reported a non-GAAP Earnings per Share(EPS) of -2.29. The EPS increased by 63.73% compared to the year before.


Income Statements
Revenue(TTM)4.43M
Net Income(TTM)4.17M
Industry RankSector Rank
PM (TTM) 94.17%
ROA 28.09%
ROE 35.39%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%55.17%
Sales Q2Q%-99.17%
EPS 1Y (TTM)63.73%
Revenue 1Y (TTM)-53.03%
MEDS financials

MEDS Ownership

Ownership
Inst Owners0.02%
Shares1.46M
Float560.00K
Ins Owners309.26%
Short Float %N/A
Short RatioN/A
MEDS Ownership

MEDS Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
VEEV VEEVA SYSTEMS INC-CLASS A22.3332.135B
WAY WAYSTAR HOLDING CORP15.564.928B
DOCS DOXIMITY INC-CLASS A15.274.681B
HTFL HEARTFLOW INC N/A1.957B
CERT CERTARA INC14.081.124B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A1.083B
CCLDO CARECLOUD INC - CCLD 8 3/4 PERP227.631.083B
SDGR SCHRODINGER INC N/A940.594M
TDOC TELADOC HEALTH INC N/A906.272M
GDRX GOODRX HOLDINGS INC-CLASS A6.21781.06M
PHR PHREESIA INC18.52726.495M
HSTM HEALTHSTREAM INC29.08653.26M
EVH EVOLENT HEALTH INC - A11.67353.899M

About MEDS

Company Profile

MEDS logo image TRxADE HEALTH, Inc. is a health services information technology company, which focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. The company is headquartered in Lutz, Florida and currently employs 8 full-time employees. The company went IPO on 2020-02-18. The firm is focused on digitalizing the retail pharmacy and health services experience by optimizing drug procurement, the prescription journey, access to physicians in the patient’s home and patient engagement in the United States. The Company’s segments include Trxade, Inc., Integra Pharma Solutions, LLC (IPS) and Superlatus. Trxade, Inc. segment provides a web-based pharmaceutical marketplace platform-business to business (B2B) sales. IPS is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to customers. The Superlatus segment holds Sapientia’s intellectual property for advanced food extrusion technology and The Urgent Company, which is a manufacturer of ice cream that is animal product-free, vegan, lactose-free, and made with plant-B2B sales. Its subsidiaries include Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, Bonum Health, LLC and others.

Company Info

TRXADE HEALTH INC

2420 Brunello Trace

Lutz FLORIDA 34639 US

CEO: Suren Ajjarapu

Employees: 8

MEDS Company Website

Phone: 18002610281

TRXADE HEALTH INC / MEDS FAQ

Can you describe the business of TRXADE HEALTH INC?

TRxADE HEALTH, Inc. is a health services information technology company, which focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. The company is headquartered in Lutz, Florida and currently employs 8 full-time employees. The company went IPO on 2020-02-18. The firm is focused on digitalizing the retail pharmacy and health services experience by optimizing drug procurement, the prescription journey, access to physicians in the patient’s home and patient engagement in the United States. The Company’s segments include Trxade, Inc., Integra Pharma Solutions, LLC (IPS) and Superlatus. Trxade, Inc. segment provides a web-based pharmaceutical marketplace platform-business to business (B2B) sales. IPS is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to customers. The Superlatus segment holds Sapientia’s intellectual property for advanced food extrusion technology and The Urgent Company, which is a manufacturer of ice cream that is animal product-free, vegan, lactose-free, and made with plant-B2B sales. Its subsidiaries include Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, Bonum Health, LLC and others.


What is the current price of MEDS stock?

The current stock price of MEDS is 7.59 USD. The price increased by 4.83% in the last trading session.


Does TRXADE HEALTH INC pay dividends?

TRXADE HEALTH INC (MEDS) has a dividend yield of 125.16%. The yearly dividend amount is currently 0.


How is the ChartMill rating for TRXADE HEALTH INC?

MEDS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Can you provide the sector and industry classification for TRXADE HEALTH INC?

TRXADE HEALTH INC (MEDS) operates in the Health Care sector and the Health Care Technology industry.


Can you provide the market cap for TRXADE HEALTH INC?

TRXADE HEALTH INC (MEDS) has a market capitalization of 11.08M USD. This makes MEDS a Nano Cap stock.